Mathew Aby J. (EVP & Chief Scientific Officer at BIOLIFE SOLUTIONS INC) disposed to issuer 404,608 shares on 2026-10-06 (4 transactions total in this filing) [$2,702,700]. [NO 10b5-1 PLAN]